litlas
ログインアカウント作成

Daniel J. Diekema

1997–2025 年に発表

169
論文数
35,355
被引用数
102
h 指数
163
i10 指数

被引用数

Daniel J. Diekema の年別被引用数1982 年: 被引用 1 件1989 年: 被引用 4 件1995 年: 被引用 1 件1998 年: 被引用 1 件1999 年: 被引用 2 件2000 年: 被引用 5 件2001 年: 被引用 21 件2002 年: 被引用 73 件2003 年: 被引用 143 件2004 年: 被引用 194 件2005 年: 被引用 272 件2006 年: 被引用 327 件2007 年: 被引用 344 件2008 年: 被引用 330 件2009 年: 被引用 412 件2010 年: 被引用 453 件2011 年: 被引用 394 件2012 年: 被引用 392 件2013 年: 被引用 320 件2014 年: 被引用 365 件2015 年: 被引用 321 件2016 年: 被引用 304 件2017 年: 被引用 240 件2018 年: 被引用 179 件2019 年: 被引用 879 件2020 年: 被引用 887 件2021 年: 被引用 722 件2022 年: 被引用 524 件2023 年: 被引用 391 件2024 年: 被引用 675 件2025 年: 被引用 292 件2026 年: 被引用 4 件1983〜1988 年は被引用が無いため表示していません1990〜1994 年は被引用が無いため表示していません1996〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,703 件、この内訳の 26.8%中国: 引用元論文 571 件、この内訳の 5.7%イギリス: 引用元論文 560 件、この内訳の 5.5%ドイツ: 引用元論文 405 件、この内訳の 4%スペイン: 引用元論文 369 件、この内訳の 3.7%オランダ: 引用元論文 339 件、この内訳の 3.4%フランス: 引用元論文 338 件、この内訳の 3.3%カナダ: 引用元論文 334 件、この内訳の 3.3%ブラジル: 引用元論文 330 件、この内訳の 3.3%イタリア: 引用元論文 330 件、この内訳の 3.3%インド: 引用元論文 308 件、この内訳の 3.1%オーストラリア: 引用元論文 284 件、この内訳の 2.8%
0%26.8%その他 31.8%

機関

分野

  • Medicine71.3%
  • Biochemistry, Genetics and Molecular Biology14.3%
  • Immunology and Microbiology6.3%
  • Agricultural and Biological Sciences2.5%
  • Health Professions1.6%
  • Environmental Science0.7%
  • その他3.3%

トピック

  • Antifungal resistance and susceptibility15.7%
  • Fungal Infections and Studies10.4%
  • Antimicrobial Resistance in Staphylococcus5.1%
  • Bacterial Identification and Susceptibility Testing4.5%
  • Antibiotic Resistance in Bacteria3.7%
  • Antibiotic Use and Resistance2.8%
  • その他57.8%

共著者

全論文

検索で開く
  1. Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

    著者: Michael A. Pfaller, Daniel J. Diekema, John Turnidge, Mariana Castanheira, Ronald N. Jones - Open Forum Infectious Diseases 2019 被引用: 820

  2. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

    著者: Daniel J. Diekema, Po‐Ren Hsueh, Rodrigo E. Mendes, Michael A. Pfaller, Kenneth V. I. Rolston, Hélio S. Sader, Ronald N. Jones - Antimicrobial Agents and Chemotherapy 2019 被引用: 639

  3. Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

    著者: Michael A. Pfaller, Daniel J. Diekema - Clinical Microbiology Reviews 2007 被引用: 4,159

  4. Principles of diagnostic stewardship: A practical guide from the Society for Healthcare Epidemiology of America Diagnostic Stewardship Task Force

    著者: Valeria Fabre, Angelina Davis, Daniel J. Diekema, Bruno Granwehr, Mary K. Hayden, Christopher F. Lowe, Christopher D. Pfeiffer, Anna Sick-Samuels, Kaede V. Sullivan, Trevor Van Schooneveld, Daniel J. Morgan - Infection Control and Hospital Epidemiology 2023 被引用: 140

  5. Survey of Infections Due toStaphylococcusSpecies: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999

    著者: Daniel J. Diekema, Michael A. Pfaller, Franz‐Josef Schmitz, Jorgelina Smayevsky, Jan Bell, Ronald N. Jones, Mondell L. Beach, SENTRY Participants Group - Clinical Infectious Diseases 2001 被引用: 1,361

  6. Practical Guidance for Clinical Microbiology Laboratories: A Comprehensive Update on the Problem of Blood Culture Contamination and a Discussion of Methods for Addressing the Problem

    著者: Gary V. Doern, Karen C. Carroll, Daniel J. Diekema, Kevin W. Garey, Mark E. Rupp, Melvin P. Weinstein, Daniel J. Sexton - Clinical Microbiology Reviews 2019 被引用: 299

  7. Diagnostic Stewardship—Leveraging the Laboratory to Improve Antimicrobial Use

    著者: Daniel J. Morgan, Preeti Malani, Daniel J. Diekema - JAMA 2017 被引用: 246

  8. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

    著者: Michael A. Pfaller, Daniel J. Diekema, David L. Gibbs, V. A. Newell, David Ellis, Viviana Cristina Tullio, AC Rodloff, Fu Wang, Tan Ai Ling - Journal of Clinical Microbiology 2010 被引用: 706

  9. Epidemiology of Invasive Mycoses in North America

    著者: Michael A. Pfaller, Daniel J. Diekema - Critical Reviews in Microbiology 2010 被引用: 904

  10. Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program

    著者: Daniel J. Diekema, Michael A. Pfaller, Dee Shortridge, Marcus Zervos, Ronald N. Jones - Open Forum Infectious Diseases 2019 被引用: 217

  11. Incidence and Outcomes Associated WithClostridium difficileInfections

    著者: Alexandre R. Marra, Eli N. Perencevich, Richard E. Nelson, Matthew H. Samore, Karim Khader, Hsiu‐Yin Chiang, Margaret L. Chorazy, Loreen A. Herwaldt, Daniel J. Diekema, Michelle Kuxhausen, Amy Blevins, Melissa Ward, Jennifer S. McDanel, Rajeshwari Nair, Erin Balkenende, Marin L. Schweizer - JAMA Network Open 2020 被引用: 137

  12. Optimal Urine Culture Diagnostic Stewardship Practice—Results from an Expert Modified-Delphi Procedure

    著者: Kimberly C. Claeys, Barbara W. Trautner, Surbhi Leekha, Kelly Coffey, Christopher J. Crnich, Daniel J. Diekema, Mohamad G. Fakih, Matthew Bidwell Goetz, Kalpana Gupta, Makoto Jones, Luci K. Leykum, Stephen Y. Liang, Lisa Pineles, Ashley Pleiss, Emily S Spivak, Katie J. Suda, Jennifer M. Taylor, Chanu Rhee, Daniel J. Morgan - Clinical Infectious Diseases 2021 被引用: 70

  13. Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008

    著者: Michael A. Pfaller, David R. Andes, Daniel J. Diekema, David L. Horn, Annette C. Reboli, Coleman Rotstein, Billy Franks, Nkechi Azie - PLoS ONE 2014 被引用: 401

  14. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008

    著者: Michael A. Pfaller, Dionysios Neofytos, Daniel J. Diekema, Nkechi Azie, Herwig‐Ulf Meier‐Kriesche, Shun-Ping Quan, D. B. HORN - Diagnostic Microbiology and Infectious Disease 2012 被引用: 391

  15. Advancing Diagnostic Stewardship for Healthcare-Associated Infections, Antibiotic Resistance, and Sepsis

    著者: Emily J. Curren, Joseph D. Lutgring, Sarah Kabbani, Daniel J. Diekema, Steven Gitterman, Ebbing Lautenbach, Daniel J. Morgan, Clare Rock, Reynolds M. Salerno, L. Clifford McDonald - Clinical Infectious Diseases 2021 被引用: 72

  16. Attributable Mortality of Nosocomial Candidemia, Revisited

    著者: Ólafur Guðlaugsson, Stephen H. Gillespie, Kyungwon Lee, Jeffery Vande Berg, Jun Hu, S. A. Messer, Loreen A. Herwaldt, Michael A. Pfaller, Daniel J. Diekema - Clinical Infectious Diseases 2003 被引用: 1,142

  17. Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyondCandida albicansandAspergillus fumigatus

    著者: Michael A. Pfaller, Daniel J. Diekema - Journal of Clinical Microbiology 2004 被引用: 692

  18. Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

    著者: Michael A. Pfaller, Daniel J. Diekema - Journal of Clinical Microbiology 2012 被引用: 491

  19. Candida krusei , a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

    著者: Michael A. Pfaller, Daniel J. Diekema, David L. Gibbs, V. A. Newell, E. Nagy, Stanislava Dobiášová, Michael G. Rinaldi, Richard Barton, Alexander V. Veselov, the Global Antifungal Surveillance Group - Journal of Clinical Microbiology 2007 被引用: 255

  20. Bioaerosol concentrations generated from toilet flushing in a hospital-based patient care setting

    著者: Samantha Dawn Knowlton, Corey Boles, Eli N. Perencevich, Daniel J. Diekema, Matthew W. Nonnenmann - Antimicrobial Resistance and Infection Control 2018 被引用: 119

  21. Improving antimicrobial use through better diagnosis: The relationship between diagnostic stewardship and antimicrobial stewardship

    著者: Tsun Sheng N. Ku, Mayar Al Mohajer, James Newton, Marie H. Wilson, Elizabeth Monsees, Mary K. Hayden, Kevin Messacar, Jamie Kisgen, Daniel J. Diekema, Daniel J. Morgan, Costi D. Sifri, Valerie M. Vaughn - Infection Control and Hospital Epidemiology 2023 被引用: 28

  22. Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases

    著者: Sandra S. Richter, Rudolph P. Galask, S. A. Messer, R. J. Hollis, Daniel J. Diekema, Michael A. Pfaller - Journal of Clinical Microbiology 2005 被引用: 425

  23. Impact of Infectious Disease Consultation in Patients With Candidemia: A Retrospective Study, Systematic Literature Review, and Meta-analysis

    著者: Takaaki Kobayashi, Alexandre R. Marra, Marin L. Schweizer, Patrick Ten Eyck, Chaorong Wu, Mohammed Alzunitan, Jorge Salinas, Marc Siegel, Dimitrios Farmakiotis, Paul G. Auwaerter, Heather Healy, Daniel J. Diekema - Open Forum Infectious Diseases 2020 被引用: 51

  24. Clinical Decision Support Systems to Reduce Unnecessary Clostridioides difficile Testing Across Multiple Hospitals

    著者: Clare Rock, Oluchi Abosi, Susan C Bleasdale, Erin Murphy Colligan, Daniel J. Diekema, Prashila Dullabh, Ayşe P. Gürses, Krysta Heaney-Huls, Jesse T. Jacob, Sheetal Kandiah, Sonam Tashi Lama, Surbhi Leekha, Jeanmarie Mayer, Alfredo J Mena Lora, Daniel J. Morgan, Patience Osei, Sara Pau, Jorge Salinas, Emily S Spivak, Eric Wenzler, Sara E. Cosgrove - Clinical Infectious Diseases 2022 被引用: 28